tazobactam has been researched along with Innate Inflammatory Response in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dittrich, P; Hoffmann, C; Kerl, H; Krause, R; Legat, FJ; Salmhofer, W; Scholz, S; Tscherpel, J; Tscherpel, T; Zenahlik, P | 1 |
Andrews, JM; Cooper, M; Logan, M; Wise, R | 1 |
1 trial(s) available for tazobactam and Innate Inflammatory Response
Article | Year |
---|---|
Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin.
Topics: Adult; Biological Assay; Blister; Drug Evaluation; Drug Interactions; Exudates and Transudates; Humans; Inflammation; Injections, Intravenous; Male; Penicillanic Acid; Piperacillin; Tazobactam; Tissue Distribution | 1991 |
1 other study(ies) available for tazobactam and Innate Inflammatory Response
Article | Year |
---|---|
Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Diabetic Foot; Extracellular Fluid; Female; Humans; Inflammation; Male; Microdialysis; Middle Aged; Penicillanic Acid; Piperacillin; Soft Tissue Infections; Tazobactam | 2005 |